Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,372.00    -66.00 (-2.71%)
Bid:
2,372.00
Ask:
2,376.00
Spread: 4.00 (0.169%)
Market Cap: £6.16b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Trading Statement

18 Jan 2006 07:00

Weir Group PLC18 January 2006 18 January 2006 THE WEIR GROUP PLC TRADING UPDATE The Weir Group PLC issues a trading update in advance of its preliminaryannouncement for the 12 months ending 30 December 2005 due to be published on 21March 2006. Overall, on a like for like basis, turnover from continuing operations for thesecond half of the year will be more than 10% above the same period last yearand all divisions reported second half profits ahead of those achieved in thefirst half. Profit before tax, restructuring costs and discontinued operationsfor the 12 months ended 30 December 2005, will be ahead of last year and towardsthe upper end of Reuters market estimates. (See Footnote.) Cash generation remains healthy despite the effects of cash restructuring costs,share buy back and increased working capital employed to support the strongerorder book. Divisional Trading Comment Engineering Products In our Engineering Products Division we achieved good levels of growth in orderinput, sales and profits when compared to 2004. The Minerals businesses, as anticipated, continue to benefit from buoyant marketconditions and were major contributors to a strong second half financialperformance for the Engineering Products Division. The Clear Liquid businesses achieved good levels of order input in the secondhalf of the year. The results from Gabbioneta in the final quarter, and theongoing restructuring of the Weir Pumps business both contributed to the secondhalf improvement in the profitability of the Engineering Products Division. All Valves & Controls businesses delivered an improved performance in the secondhalf of the year. The restructuring of the UK operation is nearing completionand the early benefits are reflected in the last quarter figures. Engineering Services The Services Division delivered improved progress in turnover in the second halfwith profits slightly ahead of those achieved in the first half of the year. Thedivision has continued to fund investments for its future growth in its coremarkets. Defence, Nuclear & Gas The Defence, Nuclear and Gas Division continued to make progress in the secondhalf of the year with stronger sales and margins from both operations. Acontinued good level of enquiries, coupled with higher levels of sales, willfurther improve conditions in 2006. Outlook for 2006 The strong level of input growth in 2005 and strength of the year-end order bookis expected to translate to higher sales across all divisions in the first halfof 2006. Restructuring benefits will be evident in the improved marginperformance from the UK Valves & Clear businesses, while the addition ofGabbioneta will also contribute to further progress against 2005. Footnote: The profit range of analysts forecasts on Reuters Knowledge Consensus at 9 January 2006 was £57.50 m to £62.00 m with consensus at £59.50m. Contact details: The Weir Group PLCMark Selway, Chief Executive Tel. 0141 637 7111 (switchboard);Helen Walker, Public Relations Manager (Mobile: 07789 032296) The Maitland Consultancy Tel. 020 7379 5151Suzanne Bartch This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Apr 20243:18 pmRNSDirector/PDMR Shareholding
10th Apr 20242:14 pmRNSDirector/PDMR Shareholding
10th Apr 20242:11 pmRNSDirector/PDMR Shareholding
5th Apr 202411:30 amRNSHolding(s) in Company
21st Mar 202410:44 amRNS2023 Annual Report and 2024 Annual General Meeting
13th Mar 202410:31 amRNSWeir opens new foundry in China
7th Mar 202411:04 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSFull Year Results
27th Feb 20249:47 amRNSDirectorate Change
7th Feb 20248:48 amRNSHolding(s) in Company
6th Feb 20248:13 amRNSWeir achieves ‘A’ score from CDP
31st Jan 20248:07 amRNSDirectorate Change
19th Dec 202310:29 amRNSNew Board Committee and Board Changes
6th Dec 20237:00 amRNSWeir announces 2026 operating margin target of 20%
5th Dec 20233:09 pmRNSDirectorate Change
4th Dec 20231:30 pmRNSWeir study on energy in mining
23rd Nov 20237:00 amRNSWeir acquires SentianAI
14th Nov 20239:54 amRNSDirector/PDMR Shareholding
7th Nov 20239:04 amRNSDirector/PDMR Shareholding
3rd Nov 20233:51 pmRNSHolding(s) in Company
3rd Nov 20233:51 pmRNSHolding(s) in Company
1st Nov 20237:01 amRNSAppointment of Chief Financial Officer
1st Nov 20237:00 amRNSQ3 Trading Update
26th Oct 20231:55 pmRNSHolding(s) in Company
24th Oct 20238:39 amRNSDirectorate Change
2nd Oct 20237:00 amRNSCapital Markets Event – 6 December 2023
18th Aug 20235:13 pmRNSDirector/PDMR Shareholding
18th Aug 20235:00 pmRNSHolding(s) in Company
18th Aug 20232:44 pmRNSDirector/PDMR Shareholding
18th Aug 20232:30 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
31st Jul 20232:19 pmRNSTotal Voting Rights
28th Jul 20234:45 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSDirectorate change
27th Jul 20237:00 amRNSAppointment of John Heasley as Finance Director
13th Jul 202311:59 amRNSStabilisation Notice
30th Jun 20233:51 pmRNSTotal Voting Rights
14th Jun 20232:31 pmRNSHolding(s) in Company
12th Jun 20232:50 pmRNSDirector / PDMR Shareholding
8th Jun 20237:00 amRNSPricing of Sustainability-Linked Notes
7th Jun 202311:35 amRNSDirector/PDMR Shareholding
7th Jun 20239:20 amRNSStabilisation Notice
5th Jun 20238:25 amRNSWeir's commitment recognised in CCLA benchmark
1st Jun 20233:34 pmRNSTotal Voting Rights
25th May 20237:30 amRNSDirector Declaration
12th May 20234:42 pmRNSDirector PDMR shareholding
12th May 20238:19 amRNSDirector/PDMR Shareholding
3rd May 202312:55 pmRNSDirector/PDMR Shareholding
3rd May 202312:51 pmRNSTotal Voting Rights
28th Apr 20232:06 pmRNSBoard Committee Change and EE NED Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.